Effect of Weak Electromagnetic Fields on the Amplitude of the Pattern Reversal Vep Response in Parkinson's Disease

References

• Ames A., Pollen L. A. Neurotransmission in central nervous tissue: a study of isolated rabbit retina. Journal of Neurophysiology 1969; 32: 424–442
   PubMed Web of Science ®Google Scholar
• Barbeau A., Campanella G., Butterworth R. F., Yamada K. Uptake and efflux of 14C dopamine in platelets: evidence for a generalized defect in Parkinson's disease. Neurology 1975; 25: 1–9
   PubMedGoogle Scholar
• Bawin S. M., Adey W. R. Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proceedings of the National Academy of Sciences, USA 1976; 73: 1999–2003
   PubMed Web of Science ®Google Scholar
• Bhaskar P. A., Vanchilingam S., Bhaskar A., Devaprabhu A., Ganesan R. A. Effect of L-dopa on visual evoked potential in patients with Parkinson's disease. Neurology 1986; 36: 1119–1121
   PubMed Web of Science ®Google Scholar
• Blackman C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss, New York 1988
   Google Scholar
• Bodis-Wollner I., Onofrj M. The visual system in Parkinson's disease. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; 323–327
   Google Scholar
• Bodis-Wollner I., Yahr M. D., Thornton J. Visual evoked potentials and the severity of Parkinson's disease. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Kent 1980; 126–146
   Google Scholar
• Bodis-Wollner I., Yahr M. D., Mylin L., Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology 1982; 11: 478–483
   PubMed Web of Science ®Google Scholar
• Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the mid-brain can regulate dopamine function both behaviourally and biochemically. The pineal: gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 327–332
   Google Scholar
• Buchsbaum M. S., Van Kammen D. P., Murphy D. L. Individual differences in average evoked responses to d-and 1-amphetamine with and without lithium carbonate in depressed patients. Psychopharmacologia 1977; 51: 129–135
   Google Scholar
• Burton S., Daya S., Potgieter B. Melatonin modulates apomorphine-induced rotational behaviour. Experientia 1991; 47: 466–469
   PubMedGoogle Scholar
• Cardinali D. P., Vacas M. I., Boyer E. E. Specific binding of melatonin in bovine brain. Endocrinology 1979; 105: 437–441
   PubMed Web of Science ®Google Scholar
• Cotzias G. C, Tang L. C, Miller S. T., Ginos J. Z. Melatonin and abnormal movement induced by L-dopa in mice. Science 1971; 173: 450–452
   PubMed Web of Science ®Google Scholar
• Cutler J. R., Aminoff M. J., Brant-Zawadzki M. Evaluation of patients with multiple sclerosis by evoked potentials and magnetic resonance imaging: a comparative study. Annals of Neurology 1986; 20: 645–648
   PubMed Web of Science ®Google Scholar
• Dinner D. S., Luders H., Hanson M., Lesser R. P., Klem G. Pattern evoked potentials (PEPs) in Parkinson's disease. Neurology 1985; 35: 610–613
   PubMed Web of Science ®Google Scholar
• Dubocovich M. L. Melatonin as a potent modulator of dopamine release in the retina. Nature 1983; 306: 782–784
   PubMed Web of Science ®Google Scholar
• Dyer R. S., Howell W. E., MacPhail R. C. Dopamine depletion slows retinal transmission. Experimental Neurology 1981; 71: 326–340
   PubMed Web of Science ®Google Scholar
• Ehle A. L., Stewart R. M., Lellelid E., Leventhal N. A. Normal checkerboard pattern reversal evoked potentials in parkinsonism. Electroencephalography and Clinical Neurophysiology 1982; 54: 336–338
   PubMedGoogle Scholar
• Frederick J. M., Rayborn M. E., Laties A. M., Lam D. M. K., Hollyfield J. G. Dopamine neurons in the human retina. Journal of Comparative Neurology 1982; 210: 65–79
   PubMed Web of Science ®Google Scholar
• Goodwin F. K., Murphy D. L., Brodie H. K. H., Bunney W. E. L-dopa, catecholamines, and behavior: a clinical and biochemical study in depressed patients. Biological Psychiatry 1970; 2: 341–366
   PubMedGoogle Scholar
• Gottfries C. G., Perris C., Roos B. E. Visual average evoked responses (AER) and monoamine metabolites in cerebrospinal fluid (CSF). Acta Psychiatrica Scandinavica 1974; 255: 135–142, (suppl)
   Google Scholar
• Halliday A. M. Clinical applications of evoked potentials. Recent advances in clinical neurology, W. B. Matthews, G. H. Glaser. Churchill Livingstone, Edinburgh 1978; 47–73
   Google Scholar
• Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427–442
   PubMed Web of Science ®Google Scholar
• Holder G. E., Bartlett J. R., Bridges P. K., Kantamanei B. D., Curzon G. Correlation between transmitter metabolite concentrations in human ventricular cerebrospinal fluid and pattern visual evoked potentials. Brain Research 1980; 188: 582–586
   PubMed Web of Science ®Google Scholar
• Kadobayashi I., Mikani M., Kato N. Inhibition and enhancement of photically evoked responses by different doses of L-dopa. Experientia 1976; 32: 343–345
   PubMedGoogle Scholar
• Karson C. N., Berman K. F., Kleinman J., Karoum F. Seasonal variation in human central dopamine activity. Psychiatry Research 1984; 11: 111–117
   PubMed Web of Science ®Google Scholar
• Kelly P. H. Drug induced motor behavior. Handbook of psychopharmacology, L. L. Iversen, S. D. Iversen, S. H. Snyder. Plenum, New York 1977; Vol. 8: 295–331
   Google Scholar
• Kopp N., Claustrat B., Tappaz M. Evidence for the presence of melatonin in the human brain. Neuroscience Letters 1980; 19: 237–242
   PubMed Web of Science ®Google Scholar
• Laudon M., Nir I., Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577–583
   PubMed Web of Science ®Google Scholar
• Miledi R. Transmitter release induced by injection of calcium ions into nerve terminals. Proceedings of the Royal Society of Biological Sciences 1973; 183: 421–428
   PubMed Web of Science ®Google Scholar
• Mintz M., Tomer R., Radwan H., Myslobodsky M. S. Visual evoked potentials in hemiparkinsonism. Electroencephalography and Clinical Neurophysiology 1981; 52: 611–616
   PubMedGoogle Scholar
• Niles L. P., Wong Y. W., Mishra R. K., Brown G. M. Melatonin receptors in brain. European Journal of Pharmacology 1979; 55: 219–220
   PubMed Web of Science ®Google Scholar
• Olcese J. M. Magnetoreception in rodents: involvement of the eyes and the pineal organ may be evidence for a chronobiological substrate. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 63–73
   Google Scholar
• Onofrj M., Bodis-Wollner I. Dopaminergic deficiency causes delayed visual evoked potentials in rats. Annals of Neurology 1982; 11: 484–490
   PubMed Web of Science ®Google Scholar
• Prieto S., Villar J. I., Bachini O. Influencias pharmacologias sobre la respuesta visual provocada en el hombre. Acta Neurologica Latinoamerica 1965; 11: 295–296
   PubMedGoogle Scholar
• Redmond D. E., Borge G. F., Buchsbaum M., Maas J. W. Evoked potential studies of brain catecholamine alterations in monkeys. Journal of Psychiatric Research 1975; 12: 97–116
   PubMed Web of Science ®Google Scholar
• Reichardt L. F., Kelly R. B. A molecular description of nerve terminal function. Annual Review of Biochemistry 1983; 52: 871–926
   PubMed Web of Science ®Google Scholar
• Reiter R. J. Changes in circadian melatonin synthesis in the pineal gland of animals exposed to extremely low frequency electromagnetic radiation: A summary of observations and speculation on their implications. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 13–27
   Google Scholar
• Rosen A. D. Magnetic field influence on acetylcholine release at the neuromuscular junction. American Journal of Physiology 1992; 262: C1418–C1422, (cell physiol, 31)
   PubMed Web of Science ®Google Scholar
• Rosen A. D., Lubowsky J. Magnetic fields influence on central nervous system function. Experimental Neurology 1987; 95: 679–687
   PubMed Web of Science ®Google Scholar
• Saletu B. Cerebral evoked potentials in psychopharmacology. Auditory evoked potentials in man. Psychopharmacology correlates of EPs. Progress in clinical neurophysiology, J. E. Desmedt. Karger, Basel 1977; Vol. 2: 175–207
   Google Scholar
• Sallanon M., Claustrat B., Touret M. Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. Acta Endocrinologica 1982; 101: 161–165
   PubMedGoogle Scholar
• Sandyk R. Weak magnetic fields as a novel therapeutic modality in Parkinson's disease. International Journal of Neuroscience 1992a; 66: 1–15
   PubMed Web of Science ®Google Scholar
• Sandyk R. Magnetic fields in the therapy of parkinsonism. International Journal of Neuroscience 1992b; 66: 209–235
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields in the treatment of Parkinson's disease with the “on-off” phenomenon. International Journal of Neuroscience 1992c; 66: 97–106
   PubMed Web of Science ®Google Scholar
• Sandyk R. A drug naive Parkinsonian patient successfully treated with electromagnetic fields. International Journal of Neuroscience 1994a; 79: 99–110
   PubMed Web of Science ®Google Scholar
• Sandyk R. Reversal of a visuoconstructional deficit in Parkinson's disease by application of external magnetic fields: a report of five cases. International Journal of Neuroscience 1994b; 75: 213–228
   PubMed Web of Science ®Google Scholar
• Sandyk R. Reversal of visuospatial hemi-inattention in patients with chronic progressive multiple sclerosis by treatment with weak electromagnetic fields. International Journal of Neuroscience 1994c; 79: 169–184
   PubMedGoogle Scholar
• Sandyk R. Treatment of Parkinson's disease with magnetic fields reduces the requirement for antiparkinsonian medications. International Journal of Neuroscience 1994d; 74: 191–201
   PubMedGoogle Scholar
• Sandyk R., Fisher H. Increased incidence neuroleptic-induced movement disorders in pinealectomized rats. International Journal of Neuroscience 1989; 48: 303–308
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Further observations on the unique efficacy of picotesla magnetic fields in Parkinson's disease. International Journal of Neuroscience 1993; 69: 167–183
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Reversal of visual neglect in Parkinson's disease by treatment with picotesla range magnetic fields. International Journal of Neuroscience 1993; 73: 93–107
   PubMedGoogle Scholar
• Sandyk R., Anninos P. A., Tsagas N., Derpapas K. Magnetic fields in the treatment of Parkinson's disease. International Journal of Neuroscience 1992; 63: 141–150
   PubMed Web of Science ®Google Scholar
• Schwab R. S., England A. C. Projection technique for evaluating surgery in Parkinson's disease. Third symposium on parkinson's disease, F. J. Gilligham, M. C. Donaldson. E. & S. Livingstone, Edinburgh 1969
   Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strengh magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Shoulson I., Glaubiger G. A., Chase T. N. On-off response: clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology 1975; 25: 1144–1148
   PubMed Web of Science ®Google Scholar
• Sokol S. Visual evoked potentials. Electrodiagnosis in clinical neurology, M. J. Aminoff. Churchill Livingstone, New York 1980; 348–369
   Google Scholar
• Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiologica Scandinavica 1971; 397: 1–48, (suppl)
   Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C, Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Chess E. K., Anderson L. E. 60-Hz electric-field effects on pineal melatonin rhythms: time course for onset and recovery. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Neuroendocrine mediated effects of electromagnetic field exposure: possible role of the pineal gland. Life Sciences 1989; 45: 1319–1332
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Effects of electromagnetic field exposure on neuroendocrine function. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 29–50
   Google Scholar
• Yaar I. The effect of levodopa treatment on the visual evoked potentials in parkinsonian patients. Electroencephalography and Clinical Neurophysiology 1980; 50: 267–274
   PubMedGoogle Scholar
• Zisapel N., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus: regulation of calcium entry. Brain research 1983; 272: 378–381
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition of dopamine release by melatonin: regional distribution in the rat brain. Brain Research 1982; 246: 161–163
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus in vitro: variations with sex and the estrous cycle. Neuroendocrinology 1983; 37: 41–47
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Circadian variations in the inhibition of dopamine release from adult and newborn rat hypothalamus by melatonin. Neuroendocrinology 1985; 40: 102–108
   PubMed Web of Science ®Google Scholar